REFERENCES
- Aurell M, Rudin A. Effect of captopril on blood pressure, renal function, the electrolyte balance and the renin-angiotensin system in Bartter's syndrome. Nephron 1983; 33: 274–278.
- Aurell M, Rudin A. Effect of captopril in Bartter's syndrome. Nephron 1985; 39: 68.
- Bartter FC, Pronove P, Gill JR, MacCardle RC, Diller E. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 1962; 33: 811–828.
- Bourke E, Delaney V. Bartter's syndrome–a dilemma of cause and effect. Nephron 1981; 27: 177–186.
- Christensen P, Green K, Leyssac PP. The relationship between urinary prostaglandin excretion rates and urine flow in conscious rats. Evaluation of the radioimmunoassay by gas chromatography-mass spectrometry. Acta Physiol Scand 1983; 117: 41–47.
- Dray F. Bartter's syndrome: contrasting patterns of prostaglandin excretion in children and adults. Clin Sci Mol Med 1978; 54: 115–118.
- Flower RJ, Moncada S, Vane JR. Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout. In: Gilman AG, Goodman LS, Rall TW, Murad F, eds. The pharmacological basis of therapeutics. 7th ed. New York: Macmillan 1985: 674–715.
- Hené RJ, Koomans HA, Dorhout Mees EJ, Stolpe Avd, Verhoef GEG, Boer P. Correction of hypokalemia in Bartter's syndrome by enalapril. Am J Kidney Dis 1987; 9: 200–205.
- Leyssac PP, Christensen P. A study of the effect of stimulated endogenous prostaglandin synthesis on urine flow, osmolar excretion rate, and renin release in hydropenic and saline loaded, anestetized rats. Acta Physiol Scand 1981; 113: 23–31.
- Morales JM, Ruilope LM, Praga M, Coto A, Alcazar JM, Prieto C, Nieto J, Rodicio JL. Long-term enalapril therapy in Bartter's syndrome. Nephron 1988; 48: 327.
- van de Stolpe A, Verhoef GEG, Hené RJ, Koomans HA, van der Vijver JCM. Total body potassium in Bartter's syndrome before and during treatment with enalapril. Nephron 1987; 45: 122–125.